Jeffrey M. Greene
Known title: DirectorCIK: 0001761809
Associated companies
Transaction History
| TRS | ▲ Buy | Grant | 4,140 | $0 | 3/14/2025 | View on chart |
| TRS | ▼ Sell | Open Market | 4,000 | $104K | 5/1/2024 | View on chart |
| TRS | ▲ Buy | Grant | 4,068 | $0 | 3/14/2024 | View on chart |
| TRS | ▲ Buy | Grant | 3,445 | $0 | 3/11/2023 | View on chart |
| TRS | ▲ Buy | Grant | 3,222 | $0 | 3/11/2022 | View on chart |
| TRS | ▲ Buy | Grant | 337 | $12K | 1/3/2022 | View on chart |
| TRS | ▲ Buy | Grant | 385 | $12K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
TriMas Sets Q3 2026 Earnings Call Date
TriMas Corporation has announced the date for its third-quarter 2026 earnings conference call. This announcement provides a specific timeline for investors to receive the company's upcoming financial results. The stock is currently trading within its 52-week range, with analysts maintaining a target price of $45.00.
TriMas Sets Q3 2026 Earnings Call Date. TriMas Corporation has announced the date for its third-quarter 2026 earnings conference call. This announcement provides a specific timeline for investors to receive the company's upcoming financial results. The stock is currently trading within its 52-week range, with analysts maintaining a target price of $45.00.